3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
26
Urinary Bladder Neoplasms
17
Carcinoma, Non-Small-Cell Lung
17
Lung Neoplasms
13
Ovarian Neoplasms
10
Nasopharyngeal Carcinoma
9
Biliary Tract Neoplasms
8
Non-Muscle Invasive Bladder Neoplasms
7
Neoplasm Metastasis
7
Cholangiocarcinoma
7
Lymphoma, Large B-Cell, Diffuse
6
Triple Negative Breast Neoplasms
5
Colorectal Neoplasms
5
Breast Neoplasms
5
Recurrence
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Neoplasms
4
Fallopian Tube Neoplasms
4
Endometrial Neoplasms
4
Carcinoma, Transitional Cell
4
Osteosarcoma
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Uterine Cervical Neoplasms
2
Urologic Neoplasms
2
Rectal Neoplasms
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
trastuzumab deruxtecan
2
Cisplatin
2
Biopsy
2
pembrolizumab
1
luprolide acetate gel depot
1
entrectinib
1
dehydroftorafur
1
darolutamide
1
ceralasertib
1
apalutamide
1
amivantamab
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Platinum
1
Pemetrexed
1
Leuprolide
1
Immunoglobulin G
1
Gonadotropin-Releasing Hormone
1
Glutamate Carboxypeptidase II
1
Fluorouracil
1
Docetaxel
1
Disulfides
1
Carboplatin
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
Gemcitabine
×
30 days
×
Clear all
No trials found.